BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 27315757)

  • 1. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
    Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
    Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA?
    Baguet JP; Steichen O; Mounier-Véhier C; Gosse P
    Ann Endocrinol (Paris); 2016 Jul; 77(3):187-91. PubMed ID: 27087531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism.
    Pechère-Bertschi A; Herpin D; Lefebvre H
    Ann Endocrinol (Paris); 2016 Jul; 77(3):226-34. PubMed ID: 27315759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis.
    Bardet S; Chamontin B; Douillard C; Pagny JY; Hernigou A; Joffre F; Plouin PF; Steichen O
    Ann Endocrinol (Paris); 2016 Jul; 77(3):208-13. PubMed ID: 27036860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery.
    Steichen O; Amar L; Chaffanjon P; Kraimps JL; Ménégaux F; Zinzindohoue F
    Ann Endocrinol (Paris); 2016 Jul; 77(3):220-5. PubMed ID: 27297451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
    Douillard C; Houillier P; Nussberger J; Girerd X
    Ann Endocrinol (Paris); 2016 Jul; 77(3):192-201. PubMed ID: 27177498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
    Weiner ID
    Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
    Reznik Y; Amar L; Tabarin A
    Ann Endocrinol (Paris); 2016 Jul; 77(3):202-7. PubMed ID: 27318644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary aldosteronism: emerging trends.
    Galati SJ; Hopkins SM; Cheesman KC; Zhuk RA; Levine AC
    Trends Endocrinol Metab; 2013 Sep; 24(9):421-30. PubMed ID: 23796656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
    Kline GA; Pasieka JL; Harvey A; So B; Dias VC
    Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
    Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
    J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary aldosteronism].
    Amar L
    Rev Prat; 2015 Jun; 65(6):817-21. PubMed ID: 26298907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Aldosteronism: Present and Future.
    Funder JW
    Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primay hyperaldosteronism--diagnostic and treatment].
    Potthoff SA; Beuschlein F; Vonend O
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2480-4. PubMed ID: 23168980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of drug-based and surgical treatments for primary aldosteronism.
    Steichen O; Lorthioir A; Zinzindohoue F; Plouin PF; Amar L
    Adv Chronic Kidney Dis; 2015 May; 22(3):196-203. PubMed ID: 25908468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism: diagnostic and treatment strategies.
    Mattsson C; Young WF
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):198-208; quiz, 1 p following 230. PubMed ID: 16932426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of primary aldosteronism.
    Vilela LAP; Almeida MQ
    Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
    Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
    Zennaro MC; Jeunemaitre X
    Ann Endocrinol (Paris); 2016 Jul; 77(3):214-9. PubMed ID: 27315758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.